Status:
COMPLETED
Validation of a Predictive Model After Complete Response in Rectal Cancer
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Background of the study: Prediction of rectal tumor response after chemoradiotherapy (CRT) might be helpful in individualizing treatment strategies, i.e., selecting patients who need less invasive su...
Detailed Description
General objective The long-term research objective is to be able to select rectum cancer patients who could receive a less invasive treatment. If prediction of response is possible, surgery may be av...
Eligibility Criteria
Inclusion
- Histological proven rectal cancer
- UICC stage I-III
- Only primary tumors; no recurrences
- Only concurrent chemoradiotherapy treatment
- Willing and able to comply with the study prescriptions
- 18 years or older
- Have given written informed consent before patient registration
- No previous radiotherapy to the pelvis
Exclusion
- No adenocarcinoma histology
- History of prior pelvis radiotherapy
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00969657
Start Date
August 1 2009
End Date
December 1 2014
Last Update
January 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MAASTRO clinic
Maastricht, Limburg, Netherlands, 6201BN